New Glucose-Lowering Drugs and Kidney Protection in CKD
Dr. Brendon Neuen George Institute for Global Health Sydney, Australia
▶︎
Management of Diabetes in CKD: 2020 KDIGO Guidelines and Beyond. Prof. Hussein Sheashaa, 14 Oct 2020
▶︎
Professor Christoph Wanner - Renoprotective effects of SGLT2 inhibitors
▶︎
Membranous Nephropathy: Sharing Breakthroughs and Recent Discoveries
▶︎
Improve Your Kidney Function In 24 Hours (5 Easy Habits)
▶︎
Professor Milton Packer - 'Heart failure – are there limits to anti-diabetic therapy with SGLT2'
▶︎
Professor David Wheeler - 'How do SGLT2 inhibitors benefit the kidney?'
▶︎
Nephrology Pearls 4/15/15
▶︎
Webinar: SGLT2 inhibitors in clinical practice
▶︎
Professor David Wheeler - Renoprotective effects of SGLT2 inhibitors
▶︎
Web Episode #002 - Renal Pathology Teaching Series (Dr. Gaut and Dr. Rajan)
▶︎
Higher Protein linked to lower Mortality in Kidney Disease?
▶︎
Emerging Therapies for IgA Nephropathy
▶︎
Understanding Your Kidney Bloodwork And When To See A Nephrologist With Dr Pandeya
▶︎
Type 2 Diabetes: The Benefits and Cost-Effectiveness of SGLT2 Inhibitors
▶︎
Kidney Disease in Pregnancy
▶︎
SGLT2 Inhibition for the Prevention and Treatment of Kidney Disease in Patients With Type 2 Diabetes
▶︎
Diabetes Care With Oral and Other Non-Insulin Agents
▶︎
Top 5 Reasons Of Foamy or Bubbly Urine: One Is Kidney Disease!
▶︎
KDIGO 2023 CKD Guideline: Evaluation, Prognostication, and Management of Kidney Disease
▶︎